Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare ...
Activist investor Nelson Peltz's Trian Fund Management plans to push Solventum for further business separations following the company's $4.1 billion filtration unit sale, the Wall Street Journal ...
Minnesota-based Solventum is one of the largest providers of sterilization devices, wound dressings, medical tape and other hospital consumables used by healthcare facilities. More than half of its ...
Nelson Peltz’s Trian Fund Management plans to push Solventum (SOLV) to separate more of its businesses after the company sold its filtration ...
The deal should allow Thermo to enter the filtration category in bioprocessing, where peers Danaher and Repligen are more ...
Investing.com -- Activist investor Trian Fund Management is reportedly planning to urge Solventum to separate additional businesses following the company's $4.1 billion deal to sell its filtration ...
Nvidia said sales, driven by the chips that power artificial intelligence, rose 78% to $39.3 billion in its latest quarter. Net income rose 80% to $22 billion. Both figures came in ahead of Wall ...
Good morning. English-Dutch food giant Unilever ousted its CEO Hein Schumacher this week, after barely one-and-a-half years ...
Read Our Latest Stock Report on SOLV Solventum Price Performance Shares of NYSE:SOLV opened at $73.08 on Monday. Solventum Co. has a twelve month low of $47.16 and a twelve month high of $96.05 ...
Allworth Financial LP increased its stake in shares of Solventum Co. (NYSE:SOLV – Free Report) by 14.7% during the 4th quarter, according to its most recent disclosure with the SEC.The ...
Shares of Solventum Corp. SOLV slipped 1.99% to $73.02 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 1.71% to 6,013.13 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results